This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled.
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: February 2011
This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled. They will take the evaluation of spine X-ray and answer to a few questions. Their medical record will be reviewed and relevant clinical findings will be collected.
- Other: Fracture evaluation
- DEXA(Dual-energy X-ray absorptiometry), X-ray
Arms, Groups and Cohorts
- Post menopausal women
- Post menopausal women between 50 to 80
Clinical Trial Outcome Measures
- The prevalence of OVCFs confirmed by history and X-ray
- Time Frame: 1 day
- The prevalence of asymptomatic (or missed) fractures
- Time Frame: 1 day
Participating in This Clinical Trial
- Subjects who were diagnosed post menopausal state – Subjects over 50 years old – The Definition of Post Menopause Women : Women whose last menstruation was over 12months ago – Subjects who visit orthopedic surgery – Subjects who have informed consents Exclusion Criteria:
- Subjects who are not confirmed as post menopause state – Subjects who do not understand the contents of questionnaire – Subjects over 80 years old – Subjects experienced any high energy fracture (including trash and fall) within 3 months. – Subjects experienced a fracture except vertebral fracture within 6 months – Unable to evaluate L-spine BMD over 2 levels because of spinal fracture or instrumentation for L-spine 1-4. – Unable to evaluate BMD at both femur because of hip fracture or instrumentation.
Gender Eligibility: Female
Minimum Age: 50 Years
Maximum Age: 79 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Provider of Information About this Clinical Study
- Overall Official(s)
- GSK Clinical Trials, Study Director, GlaxoSmithKline
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.